Evidence supporting the use of: Benfotiamine
For the health condition: Nerve Damage

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Benfotiamine is a synthetic derivative of thiamine (vitamin B1) and is primarily used to support or treat nerve damage, particularly in diabetic neuropathy. The scientific rationale for its use is based on its superior bioavailability compared to thiamine and its ability to increase intracellular thiamine diphosphate levels, which play a crucial role in glucose metabolism and nerve function. Several clinical studies, particularly from Europe and Asia, have demonstrated that benfotiamine supplementation can improve symptoms of diabetic polyneuropathy, such as pain, paresthesia, and numbness. For example, randomized controlled trials (Stracke et al., 2008; Haupt et al., 2005) have shown significant improvements in neuropathic symptoms and nerve conduction velocities with benfotiamine supplementation compared to placebo.

Despite these positive findings, some reviews and meta-analyses note that the overall quality of evidence is moderate due to small sample sizes, short study durations, and a lack of long-term outcome data. Guidelines in some countries recognize benfotiamine as an adjunct treatment for diabetic neuropathy, but it is less commonly recommended in major international guidelines, which tend to prioritize interventions with more robust and long-term safety and efficacy data. In summary, there is moderate scientific evidence supporting benfotiamine’s use for nerve damage in diabetic neuropathy, but further large-scale and long-term studies are needed to fully establish its role in clinical practice.

More about Benfotiamine
More about Nerve Damage

Products containing Benfotiamine

We currently have no products on Vitabase that contain this ingredient.